Para IV Winners & Losers - May 2018
This month’s Para IV developments suggest that there is likely to be benefit to Amneal Pharmaceuticals Inc (AMRX US) on Lialda, BioQ pharma for...
179 Views
Sun Pharma Specialty Research Pipeline – A Game Changer
Sun Pharmaceutical Indus (SUNP IN) currently has 2 specialty research products in the US market (Odomzo, Bromsite) and 4 approvals pending launch...
300 Views
IPCA Labs- The Revival Story
Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...
266 Views
BBSP Equity Asia Weekly Research 10th January 2018
Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAP• HSCEI/MXAP ratio is moving in a range pattern. Therefore downgrade...
439 Views
Emerging Markets: Outlook and Recommendations
Today's report provides a synopsis of the technical state of emerging markets, along with actionable countries and a wide variety of bottom-up...
280 Views